Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Chang

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Clinical Transplantation|June 8, 2001
Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in KoreansI Kim, S Park, B K Kim, et al.
British Journal of Cancer|February 21, 2012
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinumD H Yoon, M-H Ryu, Y S Park, et al.
British Journal of Cancer|April 21, 2012
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancerJ-C Jo, J-L Lee, M-H Ryu, et al.
Pain Medicine (Malden, Mass.)|April 23, 2004
Undergraduate medical education in pain medicine, end-of-life care, and palliative careH M Chang, R Gallagher, P D Vaillancourt, et al.
British Journal of Cancer|January 19, 2005
Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapyH J Kang, H M Chang, T W Kim, et al.
Eye (London, England)|May 11, 2013
Correlation between microRNA-34a levels and lens opacity severity in age-related cataractsK-H Chien, S-J Chen, J-H Liu, et al.
Cancer|January 3, 2001
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinomaS M Bang, D S Heo, K H Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancerH M Chang, K H Jung, T-Y Kim, et al.
British Journal of Cancer|January 26, 2008
A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancerH J Kang, H M Chang, T W Kim, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 9, 2007
Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinomaD H Koo, J L Lee, T W Kim, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Clinical Transplantation|June 8, 2001
Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in KoreansI Kim, S Park, B K Kim, et al.
British Journal of Cancer|February 21, 2012
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinumD H Yoon, M-H Ryu, Y S Park, et al.
British Journal of Cancer|April 21, 2012
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancerJ-C Jo, J-L Lee, M-H Ryu, et al.
Pain Medicine (Malden, Mass.)|April 23, 2004
Undergraduate medical education in pain medicine, end-of-life care, and palliative careH M Chang, R Gallagher, P D Vaillancourt, et al.
British Journal of Cancer|January 19, 2005
Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapyH J Kang, H M Chang, T W Kim, et al.
Eye (London, England)|May 11, 2013
Correlation between microRNA-34a levels and lens opacity severity in age-related cataractsK-H Chien, S-J Chen, J-H Liu, et al.
Cancer|January 3, 2001
Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinomaS M Bang, D S Heo, K H Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancerH M Chang, K H Jung, T-Y Kim, et al.
British Journal of Cancer|January 26, 2008
A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancerH J Kang, H M Chang, T W Kim, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 9, 2007
Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinomaD H Koo, J L Lee, T W Kim, et al.
Pageof 15